Orthobond

North Brunswick, United States Founded: 2004 • Age: 22 yrs
Anti-microbial surface coatings are functionalized for medical devices.

About Orthobond

Orthobond is a company based in North Brunswick (United States) founded in 2004.. Orthobond has raised $3.22 million across 3 funding rounds from investors including HHS. Orthobond offers products and services including Ostaguard and Antimicrobial Nanosurfaces. Orthobond operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.

  • Headquarter North Brunswick, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.22 M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.08 M (USD), Series A

    Sep 15, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orthobond

Orthobond offers a comprehensive portfolio of products and services, including Ostaguard and Antimicrobial Nanosurfaces. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Proprietary treatment for implantable devices to prevent bacterial infections.

Nanosurfaces that kill pathogens on metallic and polymeric materials mechanically.

People of Orthobond
Headcount 1-10
Employee Profiles 4
Board Members and Advisors 7
Employee Profiles
People
Chris Whitfield
Executive Vice President of Business Development and Commercialization
People
Tyler Zukofsky
Research Development Laboratory Manager
People
David L. Nichols
CEO

Unlock access to complete

Board Members and Advisors
people
Peter K. Scaturro
Director
people
Khalil Barrage
Director
people
Ken Gall
Board Of Directors

Unlock access to complete

Funding Insights of Orthobond

Orthobond has successfully raised a total of $3.22M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1.08 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $1.1M
  • First Round

    (21 Oct 2011)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2022 Amount Series A - Orthobond Valuation

investors

Apr, 2022 Amount Grant - Orthobond Valuation

investors

HHS
Oct, 2011 Amount Series A - Orthobond Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Orthobond

Orthobond has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Orthobond

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Orthobond

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Orthobond Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Orthobond

Orthobond operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Laboratory testing and contract research services are provided globally.
domain founded_year HQ Location
Provider of CRO and CDMO services
domain founded_year HQ Location
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
domain founded_year HQ Location
Branded pharmaceutical products are developed, marketed, and distributed globally.
domain founded_year HQ Location
Branded and generic prescription drugs are developed, manufactured, and marketed.
domain founded_year HQ Location
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Orthobond

Frequently Asked Questions about Orthobond

When was Orthobond founded?

Orthobond was founded in 2004 and raised its 1st funding round 7 years after it was founded.

Where is Orthobond located?

Orthobond is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.

Is Orthobond a funded company?

Orthobond is a funded company, having raised a total of $3.22M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.15M, raised on Oct 21, 2011.

What does Orthobond do?

Orthobond was founded in 2004 and is headquartered in North Brunswick, United States. Functionalized anti-microbial surface coatings are developed by the company for medical devices. Operations focus on enhancing device safety through these coatings, which are applied to prevent infections. The sector involves biotechnology and medical technology, with services centered on coating technologies tailored for healthcare applications in the U.S. market.

Who are the top competitors of Orthobond?

Orthobond's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.

What products or services does Orthobond offer?

Orthobond offers Ostaguard and Antimicrobial Nanosurfaces.

Who are Orthobond's investors?

Orthobond has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available